| scholarly article | Q13442814 |
| P2093 | author name string | Noboru Yamaguchi | |
| Yoshihisa Yamashita | |||
| Kazuaki Nonaka | |||
| Toshiyuki Saito | |||
| Shigemasa Hanazawa | |||
| Yoshikazu Masuhiro | |||
| Jose Guillermo Martinez Argueta | |||
| Maki Kagishita | |||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toll-like receptor | Q408004 |
| P304 | page(s) | 6821-6826 | |
| P577 | publication date | 2005-11-28 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Adiponectin inhibits Toll-like receptor family-induced signaling | |
| P478 | volume | 579 |
| Q33806363 | A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival |
| Q40014726 | Activation of cyclic-AMP response element binding protein contributes to adiponectin-stimulated interleukin-10 expression in RAW 264.7 macrophages |
| Q27021977 | Adipocytokines and obesity-linked disorders |
| Q35125469 | Adipocytokines: The pied pipers. |
| Q29619393 | Adipocytokines: mediators linking adipose tissue, inflammation and immunity |
| Q55548906 | Adipokine Profiling in Adult Women With Central Obesity and Hypertension. |
| Q64885042 | Adipokines Regulate the Expression of Tumor-Relevant MicroRNAs. |
| Q36718594 | Adipokines and vascular disease in diabetes |
| Q29620456 | Adipokines in inflammation and metabolic disease |
| Q37707281 | Adipokines: a link between obesity and cardiovascular disease. |
| Q36104198 | Adiponectin Suppresses UVB-Induced Premature Senescence and hBD2 Overexpression in Human Keratinocytes. |
| Q34001251 | Adiponectin actions in the cardiovascular system |
| Q37798714 | Adiponectin and Hypertension |
| Q50064404 | Adiponectin and Its Receptors Are Differentially Expressed in Human Tissues and Cell Lines of Distinct Origin |
| Q37972596 | Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease |
| Q35859734 | Adiponectin and cardiovascular health: an update |
| Q37074310 | Adiponectin and cardiovascular inflammatory responses |
| Q36753830 | Adiponectin as an anti-inflammatory factor |
| Q37353726 | Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling |
| Q37164707 | Adiponectin in inflammatory and immune-mediated diseases |
| Q35412043 | Adiponectin induces A20 expression in adipose tissue to confer metabolic benefit |
| Q36347695 | Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cells |
| Q40210296 | Adiponectin inhibits osteoclast formation stimulated by lipopolysaccharide from Actinobacillus actinomycetemcomitans |
| Q37377610 | Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10 |
| Q52884907 | Adiponectin modulates NK-cell function. |
| Q34592720 | Adiponectin regulates vascular endothelial growth factor-C expression in macrophages via Syk-ERK pathway |
| Q37339479 | Adiponectin suppresses pathological microvessel formation in retina through modulation of tumor necrosis factor-alpha expression |
| Q47630229 | Adiponectin suppression of late inflammatory mediator, HMGB1-induced cytokine expression in RAW264 macrophage cells |
| Q35768041 | Adiponectin-Mediated Analgesia and Anti-Inflammatory Effects in Rat. |
| Q26753340 | Adiponectin: a versatile player of innate immunity |
| Q35763433 | Adiponectin: an adipokine with protective features against metabolic syndrome. |
| Q36030894 | Adipose tissue and inflammatory bowel disease pathogenesis |
| Q48164917 | Adipose-tissue regulatory T cells: Critical players in adipose-immune crosstalk. |
| Q36619374 | Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice |
| Q47229023 | An improved acute gouty arthritis rat model and therapeutic effect of rhizoma Dioscoreae nipponicae on acute gouty arthritis based on the protein-chip methods |
| Q37971668 | Anaplastic lymphoma kinase: activating mechanisms and signaling pathways |
| Q47584731 | Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews. |
| Q52606115 | Bushenkangshuai Tablet Reduces Atherosclerotic Lesion by Improving Blood Lipids Metabolism and Inhibiting Inflammatory Response via TLR4 and NF-κB Signaling Pathway. |
| Q42871276 | Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis |
| Q35861003 | Characterization of Visceral and Subcutaneous Adipose Tissue Transcriptome and Biological Pathways in Pregnant and Non-Pregnant Women: Evidence for Pregnancy-Related Regional-Specific Differences in Adipose Tissue |
| Q35559298 | Clinical review: adiponectin biology and its role in inflammation and critical illness. |
| Q36979100 | Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer |
| Q35397319 | Comparison of particle-exposure triggered pulmonary and systemic inflammation in mice fed with three different diets |
| Q37808285 | Cross-talk between adipose tissue and vasculature: role of adiponectin. |
| Q37567924 | Current experimental perspectives on the clinical progression of alcoholic liver disease |
| Q47149284 | Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice |
| Q41049002 | Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditions |
| Q39638422 | Diacylglycerol kinase alpha regulates globular adiponectin-induced reactive oxygen species. |
| Q36772884 | Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome? |
| Q52338665 | Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue. |
| Q61450527 | Effects of adiponectin on osteoclastogenesis from mouse bone marrow-derived monocytes |
| Q35274208 | Effects of obesity on severity of colitis and cytokine expression in mouse mesenteric fat. Potential role of adiponectin receptor 1. |
| Q61801361 | Elevated Inflammatory Status and Increased Risk of Chronic Disease in Chronological Aging: Inflamm-aging or ? |
| Q40265790 | Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages |
| Q35601475 | Eosinophils are necessary for pulmonary arterial remodeling in a mouse model of eosinophilic inflammation-induced pulmonary hypertension |
| Q35753110 | Expression of Adiponectin Receptors on Peripheral Blood Leukocytes of Hypertensive Children Is Associated with the Severity of Hypertension |
| Q35750216 | Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy |
| Q40123569 | Ginkgo biloba extract improves insulin signaling and attenuates inflammation in retroperitoneal adipose tissue depot of obese rats |
| Q47096780 | Globular Adiponectin Limits Microglia Pro-Inflammatory Phenotype through an AdipoR1/NF-κB Signaling Pathway. |
| Q38770370 | Globular CTRP9 inhibits oxLDL-induced inflammatory response in RAW 264.7 macrophages via AMPK activation |
| Q52921832 | Globular adiponectin but not full-length adiponectin induces increased procoagulability in human endothelial cells. |
| Q28084995 | Immunological contributions to adipose tissue homeostasis |
| Q38638971 | Immunomodulatory effects of anesthetics in obese patients |
| Q48216518 | Integrated Immunomodulatory Mechanisms through which Long-Chain n-3 Polyunsaturated Fatty Acids Attenuate Obese Adipose Tissue Dysfunction |
| Q39779671 | Involvement of mTOR in globular adiponectin-induced generation of reactive oxygen species. |
| Q33575629 | Low circulating maternal adiponectin in patients with pyelonephritis: adiponectin at the crossroads of pregnancy and infection |
| Q35039346 | Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response |
| Q36283981 | Maternal plasma concentration of the pro-inflammatory adipokine pre-B-cell-enhancing factor (PBEF)/visfatin is elevated in pregnant patients with acute pyelonephritis |
| Q45161657 | Maternal plasma visfatin in preterm labor. |
| Q37108874 | Mechanisms for the anti-inflammatory effects of adiponectin in macrophages |
| Q37470376 | Mechanisms of inflammatory responses and development of insulin resistance: how are they interlinked? |
| Q92195093 | Mechanisms of obesity-induced metabolic and vascular dysfunctions |
| Q38253468 | Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. |
| Q34787288 | Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin |
| Q89719264 | Multifaceted Physiological Roles of Adiponectin in Inflammation and Diseases |
| Q35496179 | Neuropeptides, mesenteric fat, and intestinal inflammation |
| Q38363863 | Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. |
| Q37060098 | Obesity, inflammation, and the potential application of pharmaconutrition |
| Q36951691 | Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. |
| Q42871477 | Overexpression of superoxide dismutase 3 gene blocks high-fat diet-induced obesity, fatty liver and insulin resistance |
| Q42442272 | PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts |
| Q47892728 | PPARGC1A and ADIPOQ polymorphisms are associated with aggressive prostate cancer in Mexican-Mestizo men with overweight or obesity |
| Q89782645 | Phenotypes of Sarcopenic Obesity: Exploring the Effects on Peri-Muscular Fat, the Obesity Paradox, Hormone-Related Responses and the Clinical Implications |
| Q30412966 | Pro-cognitive properties of T cells |
| Q37494299 | Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. |
| Q64255446 | Pulmonary Hypertension and Obesity: Focus on Adiponectin |
| Q37236046 | Role of adipokines signaling in the modulation of T cells function. |
| Q37163429 | Role of adiponectin in human skeletal muscle bioenergetics |
| Q37978319 | Sepsis-Induced Adipokine Change with regard to Insulin Resistance |
| Q36421235 | Serum adiponectin level and different kinds of cancer: a review of recent evidence |
| Q36003975 | Short-term high fat feeding increases organ injury and mortality after polymicrobial sepsis |
| Q38301259 | Short-term treatment of RAW264.7 macrophages with adiponectin increases tumor necrosis factor-alpha (TNF-alpha) expression via ERK1/2 activation and Egr-1 expression: role of TNF-alpha in adiponectin-stimulated interleukin-10 production |
| Q39954096 | Suppression of lipopolysaccharide-stimulated tumor necrosis factor-alpha production by adiponectin is mediated by transcriptional and post-transcriptional mechanisms |
| Q34097407 | TLR4 and Insulin Resistance |
| Q41722812 | The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus |
| Q64107168 | The Impact of Aging on Adipose Function and Adipokine Synthesis |
| Q38915167 | The evolving role of adiponectin as an additive biomarker in HFrEF. |
| Q28585701 | The peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectin |
| Q28392224 | The potential interplay of adipokines with toll-like receptors in the development of hepatocellular carcinoma |
| Q26852901 | The role of adipokines in chronic inflammation |
| Q64098913 | The role of adipokines in systemic sclerosis: a missing link? |
| Q36555556 | Thiazolidinediones reduce pathological neovascularization in ischemic retina via an adiponectin-dependent mechanism |
| Q38616697 | Total and High Molecular Weight Adiponectin Expression Is Decreased in Patients with Common Variable Immunodeficiency: Correlation with Ig Replacement Therapy. |
| Q37210044 | Transcriptomic Insights into the Response of Placenta and Decidua Basalis to the CpG Oligodeoxynucleotide Stimulation in Non-Obese Diabetic Mice and Wild-Type Controls |
| Q38954621 | Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease |
| Q26778658 | Vascular repair strategies in type 2 diabetes: novel insights |
| Q39979703 | Weight Gain Alters Adiponectin Receptor 1 Expression on Adipose Tissue-Resident Helios+ Regulatory T Cells |
Search more.